Ainos, Inc. (OTCMKTS:AIMD – Get Free Report) was down 4.2% during trading on Tuesday . The company traded as low as $3.56 and last traded at $3.66. Approximately 49,304 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 948,082 shares. The stock had previously closed at $3.82.
Ainos Trading Down 4.2%
The company has a debt-to-equity ratio of 0.08, a current ratio of 1.92 and a quick ratio of 1.45. The company has a market cap of $17.05 million, a PE ratio of -4.21 and a beta of 2.25. The company’s 50 day simple moving average is $2.96 and its two-hundred day simple moving average is $1.39.
About Ainos
Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.
Featured Articles
- Five stocks we like better than Ainos
- What is Forex and How Does it Work?
- Amazon Faces Rare Downgrade—Is the Rally at Risk?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- CrowdStrike Tests $412 Support as Options Traders Turn Bullish
- Profitably Trade Stocks at 52-Week Highs
- Dueling Insider Moves: Heavy Buying Here, Big Selling There
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
